Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Lysophosphatidic acid (LPA) is a ubiquitous lysophospholipid and one of the main membrane-derived lipid signaling molecules. LPA acts as an autocrine/paracrine messenger through at least six G protein-coupled receptors (GPCRs), known as LPA1-6, to induce various cellular processes including wound he...
Saved in:
Main Authors: | Silvia Anahi Valdés-Rives (Author), Aliesha González-Arenas (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
by: Zulfikar S, et al.
Published: (2020) -
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
by: Chun Jerold, et al.
Published: (2008) -
Autotaxin and lysophosphatidic acid<sub>1 </sub>receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine
by: Aoki Junken, et al.
Published: (2010) -
Design and Development of Autotaxin Inhibitors
by: Yi Jia, et al.
Published: (2021) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
by: Bicheng Yang, et al.
Published: (2017)